Cytokine mRNA expression in tolerant heart allografts after immunosuppression with cyclosporine, sirolimus or brequinar
- 30 September 1997
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 5 (3) , 189-198
- https://doi.org/10.1016/s0966-3274(97)80037-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- IN VIVO STUDIES OF THE MAINTENANCE OF PERIPHERAL TRANSPLANT TOLERANCE AFTER CYCLOSPORINETransplantation, 1995
- CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTSTransplantation, 1995
- ENHANCED TYPE 2 AND DIMINISHED TYPE 1 CYTOKINES IN NEONATAL TOLERANCETransplantation, 1995
- QUANTITATIVE COMPARISON OF RAPAMYCIN AND CYCLOSPORINE EFFECTS ON CYTOKINE GENE EXPRESSION STUDIED BY REVERSE TRANSCRIPTASE-COMPETITIVE POLYMERASE CHAIN REACTION1Transplantation, 1994
- PREVENTION OF ORTHOTOPIC LIVER ALLOGRAFT REJECTION IN RATS WITH A SHORT-TERM BREQUINAR SODIUM THERAPYTransplantation, 1994
- The Molecular Basis of AllorecognitionAnnual Review of Immunology, 1993
- Synthesis and characterization of rat interleukin-10 (IL-10) cDNA clones from the RNA of cultured OX8− OX22− thoracic duct T cellsBiochemical and Biophysical Research Communications, 1992
- HEART ALLOGRAFTS IN MURINE SYSTEMSTransplantation, 1992
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990
- THE ROLE OF TDTH AND TC POPULATIONS IN ORGAN GRAFT REJECTIONTransplantation, 1986